Danielle Brandman, MD, MAS

Associate Professor

Education

02/2020 - Diversity, Equity, and Inclusion Champion Training, University of California

Fellowship, 2012 - Transplant Hepatology, University of California, San Francisco

M.A.S. in Clinical Research, 2011 - Advanced Training in Clinical Research, University of California, San Francisco

Fellowship, 2011 - Gastroenterology, University of California, San Francisco

Residency, 2008 - Internal Medicine, University of California, San Francisco

Honors and Awards

Resident Mentor of the Year, CTSI Resident Research Program, 2016
Haile T. Debas Academy of Medical Educators, Excellence in Teaching Award, UCSF, 2015

Publications

Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R. Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply. 2022. PMID: 35689309
Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R, Members of the Nonalcoholic Steatohepatitis Clinical Research Network. Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD). 2022. PMID: 35302256
Rinella ME, Satapathy SK, Brandman D, Smith C, Elwir S, Xia J, Gibson M, Figueredo C, Angirekula M, Vanatta JM, Sarwar R, Jiang Y, Gregory D, Agostini T, Ko J, Podila P, Gallo G, Watt KD, Siddiqui MS. Factors impacting survival in those transplanted for NASH cirrhosis: Data from the NailNASH Consortium. 2022. PMID: 35189388
Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC. Non-viral Liver Disease is the Leading Indication for Liver Transplant in the U.S. in Persons Living with Human Immunodeficiency Virus. 2021. PMID: 33749113
Brandman D. Jaundice in Polycystic Liver Disease: More Than Meets the Eye. 2021. PMID: 33868659
Xu CQ, Zhou K, Brandman D. The Updated US Preventive Services Task Force Hepatitis B Screening Recommendations-Staying Committed. 2020. PMID: 33320176
Bond AR, Bainbridge E, Doernberg SB, Babik JM, Miller S, Khanafshar E, Henry T, David A, Russell M, Brandman D, Sherman CB, Yao F, Fung M. Disseminated Legionella micdadei Infection in a Liver Transplant Patient Presenting as Pulmonary Nodules and a Laryngeal Lesion. 2021. PMID: 33434394
Brandman D. Obesity Management of Liver Transplant Waitlist Candidates and Recipients. 2020. PMID: 33978572
Price JC, Brandman D. Updated Hepatitis C Virus Screening Recommendation-A Step Forward. 2020. PMID: 32119030
Brandman D. Who Should Treat Fatty Liver Disease: Primary Care or Hepatology? 2019. PMID: 31316762
Adler E, Brandman D. Treatment of Fatty Liver Disease-Time to Implement Common Sense Measures. 2019. PMID: 31260055
Brandman D, Lin H, McManus A, Agarwal S, Gache LM, Irish W, Gollob J, Živkovic SA. Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data. 2019. PMID: 31167608
Brandman D, Terrault NA. Alcohol use in patients with non-alcoholic fatty liver: a tangled web of causality. 2019. PMID: 31245413
Siddiqui MS, Yamada G, Vuppalanchi R, Van Natta M, Loomba R, Guy C, Brandman D, Tonanscia J, Chalasani N, Neuschander-Tetri B, Sanyal AJ. Diagnostic Accuracy of Non-Invasive Fibrosis Models to Detect Change in Fibrosis Stage. 2019. PMID: 30616027
Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Brandman D, Doo E, Tonascia JA, Kleiner DE, Chalasani N, Sanyal AJ. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. 2018. PMID: 29705261
Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. New presentation of autoimmune hepatitis with erythema multiforme. 2018. PMID: 29059460
Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Abdelmalek M, Doo E, Tonascia JA, Kleiner DE, Sanyal AJ, Chalasani N. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. 2017. PMID: 28859228
Kardashian AA, Dodge JL, Roberts J, Brandman D. Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list. 2017. PMID: 28727287
Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. 2017. PMID: 28340509
Dakson A, Brandman D, Thibault-Halman G, Christie SD. Optimization of the mean arterial pressure and timing of surgical decompression in traumatic spinal cord injury: a retrospective study. 2017. PMID: 28631747
Brandman D. Editorial: are earlier referrals to transplant centres responsible for improved outcomes in patients with acute liver failure? 2017. PMID: 28370044
D. Brandman, M. Boyle, S. McPherson, M. Van Natta, A. Sanyal, K. Kowdley, B. Tetri, N. Chalassani, M. Abdelmalek, N.A. Terrault, A. McCullough, R. Bettencourt, C. Caussy, D. Kleiner, C. Behling, E. Doo, J. Tonascia, Q. Anstee, R. Loomba. PS-124 Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) Cohort. 2017. PMID:
S. Epstein, D. Brandman, J. Dodge, J. Roberts, N. Terrault. Body Mass Index (BMI) and Survival After Liver Transplantation LT): Influence of the Extremes of BMI. 2014. PMID:
L. Zeng, D. Brandman, J. Roberts, N. Terrault. Early Post-Operative Outcomes in Liver Transplantation for Nonalcoholic Steatohepatitis: A Retrospective Analysis. 2014. PMID:
Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Volume 35 of Issue 5. 2012. PMID: 22399695
Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. 2011. PMID: 21770018
Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. 2011. PMID: 22098119
Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. 2002. PMID: 12140115